Salesforce Shares Surge 23%. This Is Why the Stock Looks Like It Has a Lot More Upside Ahead.

Salesforce shares jumped 22.6% after reporting fiscal Q2 revenue up 11% YoY to $11.35B, at the top end of guidance ($11.27B–$11.35B) and above the $11.32B consensus. Agentforce ARR surged over 240% to $1.5B, Slack revenue rose 43%, and combined Agentforce + Data 360 ARR grew 210% YoY to $3.9B. The company raised/maintained FY2026 revenue guidance to $46.1B–$46.4B and guided FY Q3 revenue of $11.42B–$11.5B with adjusted EPS of $3.42–$3.44 versus $3.38 expected.

Analysis

CRM’s real read-through is not the beat itself but the change in the market’s map of AI winners: enterprise software platforms with embedded workflow data are proving they can monetize AI rather than be commoditized by it. That shifts revenue durability and pricing power toward large installed-base vendors, while putting pressure on smaller point solutions that were counting on a “software disintermediation” trade.

The second-order winner is anything tied to data unification and workflow orchestration. If customers keep expanding spend after pilot deployments, vendors with the deepest system-of-record relationships should see higher net retention and lower sales friction; that argues for a relative tailwind to CRM and, indirectly, INFA-style data infrastructure exposure. The loser set is the long tail of standalone copilots/agents that lack proprietary data or distribution, where enterprise buyers may simply bundle capabilities into existing contracts instead of adding net-new spend.

The main risk is that the AI contribution is still early-cycle and concentrated in a few logo wins, so the present ARR momentum could be front-loaded experimentation rather than steady-state consumption. The key falsifier is any sign that next quarter’s subscription growth or cRPO slows once the initial deployment wave normalizes, or that guidance is propped up by non-core investment marks rather than operating traction. Over 6-18 months, the stock likely trades on whether AI lifts deal size and retention enough to justify a higher multiple, not on headline AI rhetoric.

Key Decisions for Investors

• Buy CRM on any 3-5 day post-gap consolidation; target a re-rating toward 18-20x forward EPS over 6-12 months, with thesis invalidation on any FY26 guide reduction or sub-10% subscription growth.
• Pair trade: long CRM / short IGV for 1-3 months to isolate enterprise-platform AI monetization versus the broader SaaS basket; expect relative outperformance if the “AI kills software” trade continues to unwind.
• If the stock retraces less than 50% of the post-earnings gap, use it to initiate a 12-18 month CRM call spread; the upside is multiple expansion, while downside is limited by an already de-risked valuation.
• Watch INFA as a secondary beneficiary: if CRM’s data-layer attach rates keep accelerating, consider buying INFA on weakness only after confirming organic growth, not acquisition-driven ARR.